Toward a Shared Vision for Cancer Genomic Data
Open accessThe DOI matches its Crossref record; 6 of the 7 references it cites were found in a registry or an index.
Abstract
This FAIRsharing record describes: The National Cancer Institute’s (NCI’s) Genomic Data Commons (GDC) is a data sharing The National Cancer Institute's Genomic Data Commons (GDC) was created to promote precision medicine in oncology. It supports the import and standardization of genomic and clinical data from cancer research programs. The GDC contains NCI-generated data from some of the largest and most comprehensive cancer genomic datasets, including The Cancer Genome Atlas (TCGA) and Therapeutically Applicable Research to Generate Effective Therapies (TARGET). For the first time, these datasets have been harmonized using a common set of bioinformatics pipelines, so that the data can be directly compared. As a growing knowledge system for cancer, the GDC also enables researchers to submit data, and harmonizes these data for import into the GDC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Again, the MEKi bypass resistance was strongly correlated with the SRC activation/dasatinib sensitivity, the EMT-like stemness and the CMS4 subtype (see Fig. 6 and Fig. 7 as well as Additional File 3_Fig S5 and Fig S6).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Larkin, J., Ascierto, P. A., Dréno, B., Atkinson, V., Liszkay, G., Maio, M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408868 · Cited by 2,068
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Self-citationSharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · JAMA · doi:10.1001/jama.2015.18164 · Cited by 254
Sharing Clinical Trial Data — A Proposal from the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejme1515172 · Cited by 190
Cited by
Items 101–200 of 1,004
Merlotti, A., Sadacca, B., Arribas, Y. A., Ngoma, M., Burbage, M., Goudot, C., Houy, A., Rocañín-Arjó, A., Lalanne, A. I., Seguin‐Givelet, A., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.abm6359 · Cited by 128
“RNA-seq analysis and JET identification RNA-seq data for 3254 samples were obtained from TCGA (n = 514 LUAD, n = 498 LUSC, and n = 679 juxta-tumor), CCLE (n = 69 LUAD and n = 22 LUSC) (37), GTEx (50 samples randomly selected from 30 nondiseased tissues, when available, for a total of 1364 samples), Leucegene datasets…”
MethodJoung, J., Kirchgatterer, P. C., Singh, A., Cho, J. H., Nety, S. P., Larson, R. C., Macrae, R. K., Deasy, R., Tseng, Y., Maus, M. V., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29205-8 · Cited by 128
Cimino, P. J., Zager, M., McFerrin, L., Wirsching, H.-G., Bolouri, H., Hentschel, B., von Deimling, A., Jones, D., Reifenberger, G., Weller, M., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0443-7 · Cited by 126
“Clinical data were obtained from the Genomic Data Commons (GDC) Data Portal from the National Institutes of Health (NIH) [16].”
MethodcanSAR: update to the cancer translational research and drug discovery knowledgebase
Coker, E. A., Mitsopoulos, C., Tym, J. E., Komianou, A., Kannas, C., Di Micco, P., Villasclaras Fernandez, E., Ozer, B., Antolin, A. A., Workman, P., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1129 · Cited by 120
Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden
Qing, T., Mohsen, H., Marczyk, M., Ye, Y., O’Meara, T. A., Zhao, H., Townsend, J. P., Gerstein, M., Hatzis, C., Kluger, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16293-7 · Cited by 125
Cloud computing applications for biomedical science: A perspective
Navale, V., & Bourne, P. E. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006144 · Cited by 105
Christensen, N. R., Čalyševa, J., Fernandes, E. F. A., Lüchow, S., Clemmensen, L. S., Haugaard‐Kedström, L. M., & Strømgaard, K. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800143 · Cited by 124
CustOmics: A versatile deep-learning based strategy for multi-omics integration
Benkirane, H., Pradat, Y., Michiels, S., & Cournède, P.-H. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010921 · Cited by 125
“In this study, we use datasets extracted from the Genomic Data Commons (GDC) pan-cancer multi-omics study [40].”
Evolutionary dynamics of neoantigens in growing tumors
Lakatos, E., Williams, M. J., Schenck, R. O., Cross, W. C. H., Househam, J., Zapata, L., Werner, B., Gatenbee, C., Robertson-Tessi, M., Barnes, C. P., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-0687-1 · Cited by 121
Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer
Stackpole, M. L., Zeng, W., Li, S., Liu, C.-C., Zhou, Y., He, S., Yeh, A., Wang, Z., Sun, F., Li, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32995-6 · Cited by 122
Ultraviolet radiation–induced DNA damage is prognostic for outcome in melanoma
Trucco, L. D., Mundra, P. A., Hogan, K., García-Martínez, P. L., Virós, A., Mandal, A. K., Macagno, N., Gaudy‐Marqueste, C., Allan, D., Baenke, F., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0265-6 · Cited by 122
Oka, M., Xu, L., Suzuki, T., Yoshikawa, T., Sakamoto, H., Uemura, H., Yoshizawa, A. C., Suzuki, Y., Nakatsura, T., Ishihama, Y., et al. (2021) · Genome Biology · doi:10.1186/s13059-020-02240-8 · Cited by 108
Polynomial Regression As an Alternative to Neural NetsPreprint
Cheng, X., Khomtchouk, B. B., Matloff, N., & Mohanty, P. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1806.06850 · Cited by 119
“8.9 Big Data and Small Data: New Case-Studies in Cancer Genomics We construct two cancer datasets from the NCI Genomic Data Commons (GDC) [Grossman et al.(2016)].”
BackgroundMethodInfluentialMultiomic Integration of Public Oncology Databases in Bioconductor
Ramos, M., Geistlinger, L., Oh, S., Schiffer, L., Azhar, R., Kodali, H., de Bruijn, I., Gao, J., Carey, V. J., Morgan, M. T., et al. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.19.00119 · Cited by 118
E1 Enzymes as Therapeutic Targets in Cancer
Barghout, S. H., & Schimmer, A. D. (2020) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000053 · Cited by 118
The 21st Century Cures Act — A View from the NIH
Hudson, K. L., & Collins, F. S. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1615745 · Cited by 104
Data synthesis and adversarial networks: A review and meta-analysis in cancer imaging
Osuala, R. O., Kushibar, K., Garrucho, L., Linardos, A., Szafranowska, Z., Klein, S., Glocker, B., Díaz, O., & Lekadir, K. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102704 · Cited by 132
Skinner, K. T., Palkar, A. M., & Hong, A. L. (2023) · Cancers · doi:10.3390/cancers15174236 · Cited by 115
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)
Rempel, E., Kluck, K., Beck, S., Ourailidis, I., Kazdal, D. N., Neumann, O., Volckmar, A., Kirchner, M., Goldschmid, H., Pfarr, N., et al. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00276-6 · Cited by 114
Genomics pipelines and data integration: challenges and opportunities in the research setting
Davis‐Turak, J., Courtney, S. M., Hazard, E. S., Glen, W. B., da Silveira, W. A., Wesselman, T., Harbin, L. P., Wolf, B. J., Chung, D., & Hardiman, G. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1282822 · Cited by 112
“…the import and standardization of genomic and clinical data from cancer research programs, NCI has established the Genomics Data Commons (GDC) [6] as a next-generation cancer knowledge network addressing the receipt, quality control, integration, storage, and redistribution of standardized…”
BackgroundComputational Oncology in the Multi-Omics Era: State of the Art
de Anda‐Jáuregui, G., & Lemus, E. H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00423 · Cited by 117
“Arguably, the most successful repository of cancer multiomics is NIHs Genome Data Commons (GDC) (175).”
BackgroundA p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness
di Gennaro, A., Damiano, V., Brisotto, G., Armellin, M., Perin, T., Zucchetto, A., Guardascione, M., Spaink, H. P., Doglioni, C., Snaar-Jagalska, E. B., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0103-x · Cited by 110
“htm [16]) highlighted 13/23 miRNAs as significantly modulated in TP53-mutated (including missense mutations, deletions and insertions) compared to TP53 wild-type BC (Table 1).”
ResultReal-World Evidence In Support Of Precision Medicine: Clinico-Genomic Cancer Data As A Case Study
Agarwala, V., Khozin, S., Singal, G., O’Connell, C., Kuk, D., Li, G., Gossai, A., Miller, V., & Abernethy, A. P. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1579 · Cited by 104
Just Add Data: automated predictive modeling for knowledge discovery and feature selection
Tsamardinos, I., Charonyktakis, P., Papoutsoglou, G., Borboudakis, G., Lakiotaki, K., Zenklusen, J., Juhl, H., Chatzaki, E., & Lagani, V. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00274-8 · Cited by 59
Luo, P., Ding, Y., Lei, X., & Wu, F.-X. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00013 · Cited by 107
“The mutation data and gene expression data of these three diseases were downloaded from the NCI Genomic Data Commons (GDC) (Grossman et al., 2016).”
MethodAnatomic position determines oncogenic specificity in melanoma
Weiss, J. M., Hunter, M. V., Cruz, N. M., Baggiolini, A., Tagore, M., Ma, Y., Misale, S., Marasco, M., Simon-Vermot, T., Campbell, N. R., et al. (2022) · Nature · doi:10.1038/s41586-022-04584-6 · Cited by 101
Discovering the drivers of clonal hematopoiesis
Pich, O., Reyes-Salazar, I., Gonzalez-Perez, A., & Lopez-Bigas, N. (2022) · Nature Communications · doi:10.1038/s41467-022-31878-0 · Cited by 96
Withnell, E., Zhang, X., Sun, K., & Guo, Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab315 · Cited by 106
Sanderson, J. P., Crowley, D., Wiedermann, G. E., Quinn, L. L., Crossland, K. L., Tunbridge, H. M., Cornforth, T. V., Barnes, C. S., Ahmed, T., Howe, K., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1682381 · Cited by 105
“(NSCLC), melanoma, bladder, head and neck, and gastroesophageal cancers, MAGE-A4 is highly expressed in up to 50% of cases, 32 and thus MAGE-A4 is an attractive target for TCR therapy.”
Di Giacomo, D., La Starza, R., Gorello, P., Pellanera, F., Kalender Atak, Z., De Keersmaecker, K., Pierini, V., Harrison, C. J., Arniani, S., Moretti, M., et al. (2021) · Blood · doi:10.1182/blood.2020010510 · Cited by 39
Approaches to modernize the combination drug development paradigm
Day, D., & Siu, L. L. (2016) · Genome Medicine · doi:10.1186/s13073-016-0369-x · Cited by 104
“The US National Cancer Institute (NCI) recently launched Genomic Data Commons, an interactive data-sharing platform enabling the import and harmonization of genomic data from multiple research programs using standardized bioinformatics pipelines [67, 68].”
MethodNuclear Morphological Abnormalities in Cancer: A Search for Unifying Mechanisms
Singh, I., & Lele, T. P. (2022) · Results and problems in cell differentiation · doi:10.1007/978-3-031-06573-6_16 · Cited by 103
APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma
Cannataro, V. L., Gaffney, S. G., Sasaki, T., Issaeva, N., Grewal, N., Grandis, J. R., Yarbrough, W. G., Burtness, B. A., Anderson, K. S., & Townsend, J. P. (2019) · Oncogene · doi:10.1038/s41388-018-0657-6 · Cited by 102
“Institute Genomic Data Commons [36] and from tumornormal pairs from the University of Pittsburgh head and neck tissue bank, reported in Hedberg et al.”
BackgroundMethodInfluentialSAMHD1 Functions and Human Diseases
Coggins, S. A., Mahboubi, B., Schinazi, R. F., & Kim, B. (2020) · Viruses · doi:10.3390/v12040382 · Cited by 98
Nguyen, H., Nguyen, H., Tran, D., Drăghici, S., & Nguyen, T. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae267 · Cited by 105
“…information at the cell-type level from the huge amounts of data already collected and available in research laboratories and public repositories such as The Cancer Genome Atlas (TCGA) ( 30 ), Sequence Read Archive (SRA) ( 31 ), Gene Expression Omnibus (GEO) ( 32 ,33 ) and Ar-rayExpress ( 34 ,35 ).”
BackgroundcanSAR: update to the cancer translational research and drug discovery knowledgebase
Mitsopoulos, C., Di Micco, P., Fernandez, E. V., Dolciami, D., Holt, E., Mica, I. L., Coker, E. A., Tym, J. E., Campbell, J., Che, K. H., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1059 · Cited by 95
Alvarez, M., Benhammou, J. N., Darci-Maher, N., French, S. W., Han, S. B., Sinsheimer, J. S., Agopian, V. G., Pisegna, J. R., & Pajukanta, P. (2022) · Genome Medicine · doi:10.1186/s13073-022-01055-5 · Cited by 101
“Liver bulk RNA-seq expression data were downloaded from the GDC portal [31] as HTSeq counts for all TCGA-LIHC individuals.”
MethodGenetic Predisposition to Neuroblastoma
Barr, E. K., & Applebaum, M. A. (2018) · Children · doi:10.3390/children5090119 · Cited by 101
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer
Webster, A., Sanders, M. A., Patel, K., Dietrich, R., Noonan, R. J., Lach, F. P., White, R. R., Goldfarb, A. M., Hadi, K., Edwards, M. M., et al. (2022) · Nature · doi:10.1038/s41586-022-05253-4 · Cited by 99
PathLDM: Text conditioned Latent Diffusion Model for Histopathology
Yellapragada, S., Graikos, A., Prasanna, P., Kurç, T., Saltz, J. H., & Samaras, D. (2024) · IEEE Winter Conference on Applications of Computer Vision · doi:10.1109/wacv57701.2024.00510 · Cited by 98
Structure and evolution of double minutes in diagnosis and relapse brain tumors
Xu, K., Ding, L., Chang, T., Shao, Y., Chiang, J., Mulder, H. L., Wang, S., Shaw, T. I., Wen, J., Hover, L. D., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1912-1 · Cited by 96
Analysis and Interpretation of the Impact of Missense Variants in Cancer
Petrosino, M., Novak, L., Pasquo, A., Chiaraluce, R., Turina, P., Capriotti, E., & Consalvi, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115416 · Cited by 95
Survival Genie, a web platform for survival analysis across pediatric and adult cancers
Dwivedi, B., Mumme, H., Satpathy, S., Bhasin, S. S., & Bhasin, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-06841-0 · Cited by 95
Hinkson, I. V., Davidsen, T. M., Klemm, J. D., Chandramouliswaran, I., Kerlavage, A. R., & Kibbe, W. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00083 · Cited by 88
“…Center for Data Intensive Science, in collaboration with Ontario Institute for Cancer Research, all under an NCI contract with Leidos Biomedical Research, is a unified genomic data repository that hosts authoritative NCI reference datasets such as TCGA and TARGET (Grossman et al., 2016; NIH, 2016).”
MethodInfluentialSelf-citationCommunity-driven roadmap for integrated disease maps
Ostaszewski, M., Gebel, S., Kuperstein, I., Mazein, A., Zinovyev, A. Y., Doğrusöz, U., Hasenauer, J., Fleming, R. M. T., Novère, N. G. L., Gawron, P., et al. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby024 · Cited by 93
Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers
Krishnan, M. S., Rajan, A., Park, J., Arjunan, V., Garcia-Marques, F. J., Bermudez, A., Girvan, O., Hoang, N. S., Yin, J., Nguyen, M. H., et al. (2021) · Hepatology · doi:10.1002/hep.31614 · Cited by 93
Nature and Nurture: What Determines Tumor Metabolic Phenotypes?
Mayers, J. R., & Vander Heiden, M. G. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0165 · Cited by 83
“Nevertheless, there is hope that the broad application of tumor sequencing, even if it fails to identify directly targetable mutations, can further personalize treatment approaches to benefit a broader swath of patients (6, 9).”
BackgroundMET Exon 14 Mutation Encodes an Actionable Therapeutic Target in Lung Adenocarcinoma
Lu, X., Peled, N., Greer, J., Wu, W., Choi, P., Berger, A. H., Wong, S., Jen, K.-Y., Seo, Y., Hann, B., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1944 · Cited by 84
“For specimens that had MET exon 14 skipping at the RNA level, but lacked somatic mutation calls, exome sequencing BAMs were downloaded from the NCI Genomic Data Commons (11).”
MethodZethoven, M., Martelotto, L. G., Pattison, A., Bowen, B., Balachander, S., Flynn, A., Rossello, F. J., Hogg, A., Miller, J. A., Fryšák, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34011-3 · Cited by 91
Essegian, D., Khurana, R., Stathias, V., & Schürer, S. C. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100128 · Cited by 74
Salvadores, M., Fuster-Tormo, F., & Supek, F. (2020) · Science Advances · doi:10.1126/sciadv.aba1862 · Cited by 71
MITI minimum information guidelines for highly multiplexed tissue images
Schapiro, D., Yapp, C., Sokolov, A., Reynolds, S. M., Chen, Y.-A., Sudar, D., Xie, Y., Muhlich, J. L., Arias-Camison, R., Arena, S., et al. (2022) · Nature Methods · doi:10.1038/s41592-022-01415-4 · Cited by 88
Secondary Structural Model of Human MALAT1 Reveals Multiple Structure–Function Relationships
McCown, P. J., Wang, M. C., Jaeger, L., & Brown, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225610 · Cited by 88
“Schematics of the secondary structure of human H103 interacting with miR-23 [65,66] for (A) WT MALAT1, (B) the A4040/A4041 double deletion (red line) in breast invasive carcinoma (BRCA) [63], and (C) the U4056C substitution (red) in uterine corpus endometrial carcinoma (UCEC) [63].”
BackgroundMethodInfluentialConsensus molecular subtype classification of colorectal adenomas
Komor, M. A., Bosch, L. J., Bounova, G., Bolijn, A. S., Delis‐van Diemen, P. M., Rausch, C., Hoogstrate, Y., Stubbs, A. P., de Jong, M., Jenster, G., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5129 · Cited by 86
Zhang, X., Wang, J., Shi, J., Jia, X., Dang, S., & Wang, W. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.4846 · Cited by 86
Identification and characterization of an alternative cancer-derived PD-L1 splice variant
Hassounah, N. B., Malladi, V. S., Huang, Y., Freeman, S. S., Beauchamp, E. M., Koyama, S., Souders, N. C., Martin, S., Dranoff, G., Wong, K., et al. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2284-z · Cited by 84
Imperial, R. J. L., Toor, O. M., Hussain, A., Subramanian, J., & Masood, A. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.016 · Cited by 84
TCGA-Reports: A machine-readable pathology report resource for benchmarking text-based AI models
Kefeli, J., & Tatonetti, N. P. (2024) · Patterns · doi:10.1016/j.patter.2024.100933 · Cited by 84
“35 Each tumor sample has at most one associated pathology report (pathology_report_uuid), and each patient can have multiple samples.”
BackgroundClinical and molecular aspects of breast cancer: Targets and therapies
Godone, R. L. N., Leitão, G. M., Araújo, N., Castelletti, C. H. M., de Lima-Filho, J. L., & Martins, D. B. G. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.066 · Cited by 84
Basic of machine learning and deep learning in imaging for medical physicists
Manco, L., Maffei, N., Strolin, S., Vichi, S., Bottazzi, L., & Strigari, L. (2021) · Physica Medica · doi:10.1016/j.ejmp.2021.03.026 · Cited by 84
“TCGA ’ s dataset [24].”
Captier, N., Lerousseau, M., Orlhac, F., Hovhannisyan, N., Luporsi, M., Woff, E., Lagha, S., Feghali, P. S., Lonjou, C., Beaulaton, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55847-5 · Cited by 82
Hörst, F., Rempe, M., Becker, H., Heine, L., Keyl, J., & Kleesiek, J. (2026) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.109206 · Cited by 85
von Loga, K., Woolston, A., Punta, M., Barber, L. J., Griffiths, B. L., Semiannikova, M., Spain, G., Challoner, B. R., Fenwick, K., Simon, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13915-7 · Cited by 82
Carrillo-Perez, F., Morales, J. C., Castillo-Secilla, D., Gevaert, O., Rojas, I., & Herrera, L. J. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12040601 · Cited by 65
“The data were collected from the Cancer Genome Atlas (TCGA) program [33], which is easily accessible from the GDC portal [34].”
MethodGuanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer
Huang, F., Huffman, K. E., Wang, Z., Wang, X., Li, K., Cai, F., Yang, C., Cai, L., Shih, T. S., Zacharias, L. G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139929 · Cited by 80
“To broadly assess GTP’s roles in cancer, we used the TCGA pan-cancer gene expression data set (42) to identify gene sets whose expression correlates with GTP biosynthetic genes.”
MethodMontagna, G., Gupta, H. V., Hannum, M., Tan, K. S., Lee, J., Scarpa, J. R., Plitas, G., Irie, T., McCormick, P. J., Fischer, G. W., et al. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.10.021 · Cited by 79
“To investigate opioid receptor expression in TNBC, we used bulk RNA-seq data from The Cancer Genome Atlas (TCGA) through the National Institutes of Health/National Cancer Institute Genomic Data Commons public database.(24) Tumour sample RNA-seq data were drawn from a cohort of 173 TNBC patients,(25) while another coho…”
MethodPhillips, J. W., Pan, Y., Tsai, B. L., Xie, Z., Demirdjian, L., Xiao, W., Yang, H. T., Zhang, Y., Lin, C. H., Cheng, D., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915975117 · Cited by 76
“RNA-Seq Fastq files from TCGA primary prostate cancer and adjacent benign samples were downloaded from GDC via gdcclient (84).”
MethodSakthikumar, S., Roy, A., Haseeb, L., Pettersson, M. E., Sundström, E., Marinescu, V. D., Lindblad‐Toh, K., & Forsberg‐Nilsson, K. (2020) · Genome biology · doi:10.1186/s13059-020-02035-x · Cited by 76
Cho, J.-W., Park, S., Kim, G., Han, H., Shim, H. S., Shin, S., Bae, Y., Park, S. Y., Ha, S., Lee, I., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26362-0 · Cited by 75
The tumor suppressor microRNA let-7 inhibits human LINE-1 retrotransposition
Tristán-Ramos, P., Rubio-Roldán, A., Peris, G., Sánchez, L., Amador‐Cubero, S., Viollet, S., Cristofari, G., & Heras, S. R. (2020) · Nature Communications · doi:10.1038/s41467-020-19430-4 · Cited by 76
Data Lakes, Clouds, and Commons: A Review of Platforms for Analyzing and Sharing Genomic Data
Grossman, R. L. (2019) · Trends in Genetics · doi:10.1016/j.tig.2018.12.006 · Cited by 74
“The NCRDC spans the GDC [30] and the Cloud Resources [61], so that both AWS and the GCP can be used to both analyze data from the GDC as well as to support integrative data analysis across data uploaded by researchers with data from the GDC and other third party datasets.”
MethodInfluentialSelf-citationAffinityNet: Semi-Supervised Few-Shot Learning for Disease Type Prediction
Ma, T., & Zhang, A. (2019) · Proceedings of the AAAI Conference on Artificial Intelligence · doi:10.1609/aaai.v33i01.33011069 · Cited by 73
Rajendran, S. H., Hu, Y., Canella, A., Peterson, C. R., Gross, A. C., Cam, M., Nazzaro, M., Haffey, A., Harmancı, A. S., Distefano, R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112197 · Cited by 73
Distinct molecular etiologies of male and female hepatocellular carcinoma
Natri, H. M., Wilson, M. A., & Buetow, K. H. (2019) · BMC Cancer · doi:10.1186/s12885-019-6167-2 · Cited by 73
“TCGA LIHC Affymetrix Human Omni 6 array genotype data, whole exome sequencing 83 (WES) and RNAseq data (dbGaP accession #11368) were downloaded from NCI Genomic Data 84 Commons [15].”
MethodInfluentialVariability in estimated gene expression among commonly used RNA-seq pipelines
Arora, S., Pattwell, S. S., Holland, E. C., & Bolouri, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-59516-z · Cited by 73
Fenstermaker, M., Tomlins, S. A., Singh, K., Wiens, J., & Morgan, T. M. (2020) · Urology · doi:10.1016/j.urology.2020.05.094 · Cited by 72
Nguyen, T. T., Lee, H., Burt, B. M., Wu, J., Zhang, J. J., Amos, C. I., & Cheng, C. (2022) · Genome Medicine · doi:10.1186/s13073-021-01010-w · Cited by 72
“Abbreviations NSCLC: Non-small cell lung cancer; ICBT: Immune checkpoint blockade therapy; TIME: Tumor immune microenvironment; LUAD: Lung adenocarcinoma; TCGA: The Cancer Genome Atlas; NCI: National Cancer Institute; CPTAC: Clinical Proteomic Tumor Analysis Consortium; GDC: Genomic Data Commons; GDSC: The Genomics of…”
MethodInfluentialPeuker, K., Strigli, A., Tauriello, D. V. F., Hendricks, A., Schönfels, W. V., Burmeister, G., Brosch, M., Herrmann, A., Krüger, S., Nitsche, J., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.03.008 · Cited by 72
Precision medicine needs pioneering clinical bioinformaticians
Goméz-López, G., Dopazo, J., Cigudosa, J. C., Valencia, A., & Al‐Shahrour, F. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx144 · Cited by 72
A recurrent cancer-associated substitution in DNA polymerase ε produces a hyperactive enzyme
Xing, X., Kane, D. P., Bulock, C. R., Moore, E. A., Sharma, S., Chabes, A., & Shcherbakova, P. V. (2019) · Nature Communications · doi:10.1038/s41467-018-08145-2 · Cited by 72
Green, A. M., Budagyan, K., Hayer, K. E., Reed, M. A., Savani, M. R., Wertheim, G. B. W., & Weitzman, M. D. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3394 · Cited by 71
“Data were normalized using the bioconducter package DESeq2 (27).”
Ibrahim, S., Dakik, H., Vandier, C., Chautard, R., Paintaud, G., Mazurier, F., Lecomte, T., Guéguinou, M., & Raoul, W. (2019) · Cancers · doi:10.3390/cancers11040561 · Cited by 71
“gov/repository) [44] and were log2 transformed after the addition of one (log2(x + 1)) prior to analysis.”
MethodGomes, L. R., Rocha, C. R. R., Martins, D. J., Fiore, A. P. Z. P., Kinker, G. S., Bruni‐Cardoso, A., & Menck, C. F. M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1689-8 · Cited by 71
TYK2: An Upstream Kinase of STATs in Cancer
Wöss, K., Simonović, N., Strobl, B., Macho‐Maschler, S., & Müller, M. M. (2019) · Cancers · doi:10.3390/cancers11111728 · Cited by 71
Sorokin, M., Ignatev, K., Poddubskaya, E. V., Vladimirova, U., Гайфуллин, Н., Lantsov, D., Garazha, A., Allina, D. O., Suntsova, M., Barbara, V., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8050114 · Cited by 70
“In addition to the FFPE data, we also observed a good correlation between RNA sequencing data and immunohistochemistry for the freshly frozen BC samples from the TCGA project database [36] with known HER2, ER, and PGR statuses.”
MethodInfluentialDisease Gene Prediction by Integrating PPI Networks, Clinical RNA-Seq Data and OMIM Data
Luo, P., Tian, L., Ruan, J., & Wu, F. (2017) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2017.2770120 · Cited by 70
“The cancer case and control gene expression data are downloaded from the NCI’s Genomic Data Commons (GDC) [29].”
MethodImplementing the FAIR Data Principles in precision oncology: review of supporting initiatives
Vesteghem, C., Brøndum, R. F., Sønderkær, M., Sommer, M., Schmitz, A., Bødker, J. S., Dybkær, K., El‐Galaly, T. C., & Bøgsted, M. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz044 · Cited by 70
“Looking at actual data-sharing projects, the Genomic Data Commons (GDC) [33, 34] is a major resource.”
BackgroundMAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling
Ngan, H.-L., Liu, Y., Fong, A., Poon, P. H. Y., Yeung, C. K., Chan, S. S. M., Lau, A., Piao, W., Li, H., Tse, J. S. W., et al. (2020) · Life Science Alliance · doi:10.26508/lsa.201900545 · Cited by 70
“…3A%5B%22TCGA-HNSC%22%5D%7D%7D%2C%7B%22op%22%3A%22in %22%2C%22content%22%3A%7B%22 fi eld%22%3A%22 fi les.data_category %22%2C%22value%22%3A%5B%22Transcriptome%20Pro fi ling%22% 5D%7D%7D%5D%7D&searchTableTab= fi les) (Grossman et al, 2016) using GDCRNATools (R package).”
Franch‐Expósito, S., Bassaganyas, L., Vila-Casadesús, M., Hernández‐Illán, E., Esteban-Fabró, R., Díaz‐Gay, M., Lozano, J. J., Castells, A., Llovet, J. M., Castellví-Bel, S., et al. (2020) · eLife · doi:10.7554/elife.50267 · Cited by 69
Multi-Omics Model Applied to Cancer Genetics
Pettini, F., Visibelli, A., Cicaloni, V., Iovinelli, D., & Spiga, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115751 · Cited by 70
Yin, Q., Chen, W., Zhang, C., & Wei, Z. (2022) · Laboratory Investigation · doi:10.1038/s41374-022-00801-y · Cited by 69
“Cancer is a heterogeneous disease driven by diverse gene mutations, and the analysis of genomics data is essential to extract molecular factors related to disease progression and prognosis 1 .”
BackgroundKaur, H., Dhall, A., Kumar, R., & Raghava, G. P. S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01306 · Cited by 69
Kanavati, F., Toyokawa, G., Momosaki, S., Takeoka, H., Okamoto, M., Yamazaki, K., Takeo, S., Iizuka, O., & Tsuneki, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-87644-7 · Cited by 68
Camarena, M. E., Theunissen, P., Ruiz, M., Ruiz‐Orera, J., Calvo-Serra, B., Castelo, R., Castro, C., Sarobe, P., Fortes, P., Perera‐Bel, J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn3628 · Cited by 68
Grinat, J., Heuberger, J., Vidal, R. O., Goveas, N., Kosel, F., Berenguer, A., Kranz, A., Wulf-Goldenberg, A., Behrens, D., Melcher, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20222-z · Cited by 67
Li, X., Cooper, N. G. F., O’Toole, T. E., & Rouchka, E. C. (2020) · BMC Genomics · doi:10.1186/s12864-020-6502-7 · Cited by 66
“Two benchmark MAQC (Microarray Quality Control Project) datasets [34, 46, 47], five real RNA-seq datasets from The Cancer Genome Atlas (TCGA) website [48], and simulated data with varying read depths are used in this study.”
MethodLoss-of-function uORF mutations in human malignancies
Schulz, J., Mah, N., Neuenschwander, M., Kischka, T., Ratei, R., Schlag, P. M., Castaños‐Vélez, E., Fichtner, I., Tunn, P., Denkert, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19201-8 · Cited by 66
CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity
Park, M.-H., Kim, A. K., Manandhar, S., Oh, S.-Y., Jang, G.-H., Kang, L., Lee, D., Hyeon, D. Y., Lee, S.-H., Lee, H., et al. (2019) · eLife · doi:10.7554/elife.46012 · Cited by 66
Foltz, S. M., Greene, C. S., & Taroni, J. (2023) · Communications Biology · doi:10.1038/s42003-023-04588-6 · Cited by 66
“GBM RNA-seq upper quartile FPKM gene expression data came from the National Cancer Institute Genomic Data Commons TCGA Pan-Cancer Atlas 38,39 .”
MethodProteogenomic insights suggest druggable pathways in endometrial carcinoma
Dou, Y., Katsnelson, L., Gritsenko, M., Hu, Y., Reva, B. A., Hong, R., Wang, Y.-T., Kołodziejczak, I., Lu, R. J.-H., Tsai, C., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.07.007 · Cited by 65
Metadata
- Authors
- Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M.
- Affiliations
- Ontario Institute for Cancer Research (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-09-22
- Volume
- 375
- Issue
- 12
- Pages
- 1109-1112
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6309165
- OpenAlex
- W2521492299
- Cited by
- 1,680
- References
- 7
- Citations by year
- 2026: 111 · 2025: 141 · 2024: 192 · 2023: 223 · 2022: 231 · 2021: 238 · 2020: 190 · 2019: 171 · 2018: 114 · 2017: 64 · 2016: 5
- FWCI
- 49.40
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (Z01BC008905)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Keywords
- Genomic Data Commons, data sharing, data harmonization, precision oncology, TCGA, targets, bioinformatics pipeline, clinical data standardization, data interoperability
- MeSH terms
- DNA, Neoplasm, Humans, Neoplasms, United States, Genome, Human, National Cancer Institute (U.S.), Precision Medicine, Datasets as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.